- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2407
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Patient-derived heavy chain antibody targets cell surface HSP90 on breast tumors ; volume:15 ; number:1 ; day:3 ; month:9 ; year:2015 ; pages:1-19 ; date:12.2015
BMC cancer ; 15, Heft 1 (3.9.2015), 1-19, 12.2015
- Creator
-
Devarakonda, Charan V.
- Contributor
-
Kita, Daniel
Phoenix, Kathryn N.
Claffey, Kevin P.
SpringerLink (Online service)
- DOI
-
10.1186/s12885-015-1608-z
- URN
-
urn:nbn:de:1111-2016110619435
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:44 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Devarakonda, Charan V.
- Kita, Daniel
- Phoenix, Kathryn N.
- Claffey, Kevin P.
- SpringerLink (Online service)
Other Objects (12)
Characterization of single chain antibody targets through yeast two hybrid
HSP90-stabilized proteins as therapeutic targets in cancer
Widespread amyloidogenicity potential of multiple myeloma patient-derived immunoglobulin light chains
Targeting Patient-Derived Orthotopic Gastric Cancers with a Fluorescent Humanized Anti-CEA Antibody
Opportunities and challenges of patient-derived models in cancer research: patient-derived xenografts, patient-derived organoid and patient-derived cells
Molecular mechanisms of antibody light chain amyloidogenicity
Molecular Insights into Antibody Light Chain Pathogenicity
miR-15a targets the HSP90 co-chaperone Morgana in chronic myeloid leukemia
HSP90 inhibitors disrupt a transient HSP90-HSF1 interaction and identify a noncanonical model of HSP90-mediated HSF1 regulation
Phosphoregulation des Hsp90-Chaperonsystems
Hsp90 depletion goes wild
Heat shock protein 90 (Hsp90) inhibition targets canonical TGF-β signalling to prevent fibrosis
Characterization of single chain antibody targets through yeast two hybrid
HSP90-stabilized proteins as therapeutic targets in cancer
Widespread amyloidogenicity potential of multiple myeloma patient-derived immunoglobulin light chains
Targeting Patient-Derived Orthotopic Gastric Cancers with a Fluorescent Humanized Anti-CEA Antibody
Opportunities and challenges of patient-derived models in cancer research: patient-derived xenografts, patient-derived organoid and patient-derived cells
Molecular mechanisms of antibody light chain amyloidogenicity
Molecular Insights into Antibody Light Chain Pathogenicity
miR-15a targets the HSP90 co-chaperone Morgana in chronic myeloid leukemia
HSP90 inhibitors disrupt a transient HSP90-HSF1 interaction and identify a noncanonical model of HSP90-mediated HSF1 regulation
Phosphoregulation des Hsp90-Chaperonsystems
Hsp90 depletion goes wild
Heat shock protein 90 (Hsp90) inhibition targets canonical TGF-β signalling to prevent fibrosis
Characterization of single chain antibody targets through yeast two hybrid
HSP90-stabilized proteins as therapeutic targets in cancer
Widespread amyloidogenicity potential of multiple myeloma patient-derived immunoglobulin light chains
Targeting Patient-Derived Orthotopic Gastric Cancers with a Fluorescent Humanized Anti-CEA Antibody
Opportunities and challenges of patient-derived models in cancer research: patient-derived xenografts, patient-derived organoid and patient-derived cells
Molecular mechanisms of antibody light chain amyloidogenicity
Molecular Insights into Antibody Light Chain Pathogenicity
miR-15a targets the HSP90 co-chaperone Morgana in chronic myeloid leukemia
HSP90 inhibitors disrupt a transient HSP90-HSF1 interaction and identify a noncanonical model of HSP90-mediated HSF1 regulation
Phosphoregulation des Hsp90-Chaperonsystems
Hsp90 depletion goes wild